Immunogenicity, reactogenicity and tolerability of dengue vaccine, following prior vaccination with dengue vaccine or yellow fever vaccine, in subjects aged 2-45 years
Phase of Trial: Phase I
Latest Information Update: 05 Nov 2010
At a glance
- Drugs CYD TDV (Primary) ; Yellow fever vaccine
- Indications Dengue
- Focus Pharmacodynamics
- 05 Nov 2010 New trial record.